Raymond James & Associates Bristol Myers Squibb CO Transaction History

Raymond James & Associates

$150 Billion
Q2 2024

A detailed history of Raymond James & Associates transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Raymond James & Associates holds 3,187,027 shares of BMY stock, worth $162 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

3,187,027

Previous 3,383,549 5.81%

Holding current value

$162 Million

Previous $183 Million 27.87%

% of portfolio

0.09%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$40.25 - $52.99 $7.91 Million - $10.4 Million	-196,522 Reduced 5.81%	3,187,027 $132 Million
Q1 2024 Apr 22, 2024	BUY	$47.98 - $54.4 $44.6 Million - $50.6 Million	929,665 Added 37.89%	3,383,549 $183 Million
Q4 2023 Jan 16, 2024	SELL	$48.48 - $57.85 $26 Million - $31.1 Million	-537,293 Reduced 17.96%	2,453,884 $126 Million
Q3 2023 Oct 24, 2023	SELL	$57.89 - $64.73 $3.29 Million - $3.67 Million	-56,748 Reduced 1.86%	2,991,177 $174 Million
Q2 2023 Jul 25, 2023	BUY	$63.71 - $70.74 $14.4 Million - $15.9 Million	225,434 Added 7.99%	3,047,925 $195 Million
Q1 2023 Apr 14, 2023	BUY	$65.71 - $74.53 $2.62 Million - $2.97 Million	39,876 Added 1.43%	2,822,491 $196 Million
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $18.1 Million - $21.4 Million	-263,723 Reduced 8.66%	2,782,615 $200 Million
Q3 2022 Oct 25, 2022	SELL	$0.13 - $76.84 $27,816 - $16.4 Million	-213,971 Reduced 6.56%	3,046,338 $217 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $37.1 Million - $40.9 Million	-511,241 Reduced 13.56%	3,260,309 $251 Million
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $13 Million - $15.6 Million	211,655 Added 5.95%	3,771,550 $275 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $11.6 Million - $13.5 Million	215,662 Added 6.45%	3,559,895 $222 Million
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $154,078 - $180,483	2,604 Added 0.08%	3,344,233 $198 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $6.04 Million - $6.57 Million	97,489 Added 3.01%	3,341,629 $223 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $20.2 Million - $22.7 Million	-340,067 Reduced 9.49%	3,244,140 $205 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $15.2 Million - $17.2 Million	263,291 Added 7.93%	3,584,207 $222 Million
Q3 2020 Nov 04, 2020	BUY	$57.43 - $63.64 $15.1 Million - $16.7 Million	262,374 Added 8.58%	3,320,916 $200 Million
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $26.1 Million - $30.5 Million	475,504 Added 18.41%	3,058,542 $180 Million
Q1 2020 Apr 21, 2020	BUY	$46.4 - $67.43 $360,296 - $523,593	7,765 Added 0.3%	2,583,038 $144 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $24.7 Million - $32.2 Million	502,211 Added 24.23%	2,575,273 $165 Million
Q3 2019 Nov 07, 2019	BUY	$42.77 - $50.71 $12.7 Million - $15 Million	296,256 Added 16.67%	2,073,062 $105 Million
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $2.24 Million - $2.48 Million	50,214 Added 2.91%	1,776,806 $80.6 Million
Q1 2019 May 06, 2019	BUY	$45.12 - $53.8 $29.5 Million - $35.1 Million	653,060 Added 60.83%	1,726,592 $82.4 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $2.56 Million - $3.32 Million	-52,463 Reduced 4.66%	1,073,532 $55.8 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $2.44 Million - $2.76 Million	44,259 Added 4.09%	1,125,995 $69.9 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $5.54 Million - $6.91 Million	-109,662 Reduced 9.2%	1,081,736 $59.9 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $3.73 Million - $4.29 Million	62,221 Added 5.51%	1,191,398 $75.4 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $1.59 Million - $1.73 Million	-26,463 Reduced 2.29%	1,129,177 $69.2 Million
Q3 2017 Nov 13, 2017	SELL	$55.23 - $63.74 $780,620 - $900,901	-14,134 Reduced 1.21%	1,155,640 $73.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,169,774	1,169,774 $65.2 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Bristol Myers Squibb CO Transaction History